Hologic (HOLX) said Thursday that its automated molecular tests designed for detecting the most common causes of infectious gastroenteritis have received 510(k) clearance from the US Food and Drug Administration.
The Panther Fusion Gastrointestinal Bacterial and Expanded Bacterial Assays have also received CE marking in the European Union in accordance with In Vitro Diagnostic Regulation, the company said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.